ARC Medical Inc.

Looking forward to meeting up with prospective investors, collaborators, and partners at the 10th LSX World Congress in London! The event, taking place on April 29-30, 2024, is a leading life science partnering, strategy, and investment conference. ARC Medical Inc.'s innovative fluid medical devices for the prevention or reduction of surgical adhesions are generating lots of productive discussions. 👉 As CEO, I will be presenting ARC's background and plans on the “Showcase MedTech” stage on Monday April 29th at 12:10 pm (UK time) 👉 and will be contributing as a part of an expert panel on Tuesday April 30th at 12:10 pm (UK time) titled: “Deciphering the Path to US Market Entry – What Does It Take?” If you're at the Congress or in the area, let's meet up for coffee and chat! ☕ #health #healthcare #entrepreneurship #ceo #venturecapital

Roses are red, violets are blue, the #LSIAlumni reached more milestones, each one a new breakthrough 🌹 This week, the LSI Alumni announced an FDA 510(k) clearance, FDA Breakthrough Device Designation, new board members, and much more on the road to #LSIUSA24. Your 60 second news recap: Accelus → Announced the appointment of CEO, Kevin McGann & industry veteran, Bernie Haffey to their Board of Directors. ARC Medical Inc. — Chris Springate → Announced the first deployment of its novel JOCOAT™ fluid medical device for the prevention or reduction of surgical adhesions in two surgical patients. binx health — Jeffrey R. Luber → Entered into a national distribution agreement with Cardinal Health to expand access to care with its binx io platform. Canary Medical Inc. — Bill Hunter → Announced the completion of the first-in-human limited feasibility trial of their Cardiac Auscultation (Acoustic) monitoring sensor device. Earlybird Venture Capital — Thom Rasche, John Yianni → Announced the close of its Earlybird Health Fund at €173 million ($186 million). Efemoral Medical — Christopher Haig → Granted FDA Breakthrough Device Designation for its novel Efemoral Vascular Scaffold System (EVSS). FundamentalVR — Richard Vincent → Announced the appointment of Carlos de Torres Gimeno to its board of directors. Interventional Systems — Pedro Costa → Announced a partnership with IJX Optical Tracking to build the next-generation solution in shoulder surgery. neuro42 — Abhita Vohra, Amit Vohra, PhD, MBA → Received FDA 510(k) clearance for its portable diagnostic MRI scanner. NEXT Life Sciences, Inc. — L.R. Fox, Emily Collins → Announced successful clinical evaluation of its new proprietary delivery method for Plan A™ Contraception for Men. ProArc Medical — Gilad Hizkiyahu → Awarded a grant from the Israel Innovation Authority. Rna Diagnostics Inc. — John Connolly → Announced the successful completion of phase 1 of the BREVITY clinical trial - aiming to validate the utility of the RNA Disruption Assay(RDA™) Sensome — Franz Bozsak → Enrolled the first patients into the SEPARATE feasibility clinical study using the Clotild® Smart Guidewire in peripheral artery disease (PAD). The Shape Sensing Company — Ryan DeBoer → Announced the formation of its new Advisory Board. The members include: Dr. Dennis Gable, Dr. Ross Milner, Dr. Pedro Teixeira, Frank Grillo, and Burton Tripathi. THINK Surgical — Stuart Simpson → Entered into a new Collaboration Agreement with LINK. Through this collaboration, THINK Surgical will add the LinkSymphoKnee System to THINK Surgical's ID-HUB™ Varia Ventures  → Announced the appointment of Bryce Klontz as Venture Partner. ZKR Orthopedics — David Cash → Received FDA IDE approval for a multicenter prospective clinical trial that will evaluate the company's LIFT implant to treat later stage patellofemoral cartilage degeneration in adult patients. Congratulations to all of the LSI Alumni who hit major milestones this week!

🚀 Exciting Innovations in Surgical Care: A Deep Dive with ARC Medical's CEO, Dr. Chris Springate I recently had the privilege of reading an insightful interview with Dr. Chris Springate, CEO of ARC Medical Inc., on The Clinical Trial Vanguard. The conversation delved into ARC's pioneering work in surgical adhesion prevention, a critical area that affects post-operative recovery and patient outcomes. 🔍 ARC Medical is addressing a significant medical need with their liquid polysaccharide device that forms a physical barrier to prevent tissues from sticking together post-surgery. This innovation could dramatically reduce complications and the need for additional surgeries. 📈 The regulatory journey has been insightful, with clear discussions with the FDA and PMDA, especially for gynecological and abdominal indications. ARC's comprehensive regulatory strategy is paving the way for future approvals and broad application in the medical field. 🧪 Clinical trials are at the heart of ARC's progress, with methodologies focusing on safety and efficacy. Their adaptive design trials are particularly noteworthy, as they offer a phased approach to assessing their product's impact. 💡 Consistency in application across diverse surgical procedures is a challenge that ARC Medical has tackled head-on. Their device's fluidity ensures uniform application, integrating seamlessly into various surgical workflows. 🔬 For laparoscopic surgeries, ARC has adapted its research to ensure that its device can be introduced through a trocar, maintaining efficacy across surgical techniques. 🛡️ Intellectual property is key, and ARC's proactive patent strategy has secured their innovations globally, ensuring market longevity. 🌐 Looking ahead, ARC Medical is poised to become a leader in preventing surgical adhesions, with plans to expand clinical trials and partnerships globally. 💬 Dr. Springate's parting insight for clinical researchers is a testament to the transformative potential of patient-centric clinical research. Persistence in quality protocols and collaborations with top clinical researchers and sites leads to high-quality data. Join me in applauding ARC Medical for their commitment to enhancing post-operative outcomes and shaping the future of surgical care. Let's engage with their journey and support innovations that make surgeries safer and recovery uncomplicated. #Innovation #Healthcare #SurgicalCare #ClinicalTrials #MedicalDevices #PatientCare #RegulatoryAffairs #ARCmedical